Applied DNA Sciences to Present at the 2017 Disruptive Growth Company Showcase NYC on September 27

STONY BROOK, N.Y.–(BUSINESS WIRE)– Applied
DNA Sciences, Inc. (NASDAQ: APDN), announced that Dr. James Hayward,
president & CEO, will present at the 2017 Disruptive Growth Company
Showcase at the Grand Hyatt in New York City on Wednesday, September 27
at 2:30 p.m. ET. Dr. Hayward will present to an audience of investors
and industry professionals and will be available for one-on-one meetings
with institutional investors.

Dr. Hayward’s presentation at the Showcase will also be webcast through
the Investor Relations section of the company’s website at www.adnas.com.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based
technology solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies,
governments and consumers from theft, counterfeiting, fraud and
diversion. The proprietary DNA-based “CertainT™” platform can be used to
identify, tag, test, and track products, to help assure authenticity,
origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the
heart of a family of uncopiable, security and authentication solutions
such as SigNature® T and fiberTyping®, targeted toward textiles and
apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and
digitalDNA®, providing powerful track-and-trace. All provide a forensic
chain of evidence, and can be used to prosecute perpetrators. Applied
DNA Sciences is also engaged in the large-scale production of specific
DNA sequences using the polymerase chain reaction.

Visit adnas.com
for more information. Follow us on Twitter
and LinkedIn.
Join our mailing
list.

The Company’s common stock is listed on NASDAQ under the symbol APDN,
and its warrants are listed under the symbol APDNW.

Forward Looking Statements

The statements made by APDN in this press release may be
« forward-looking » in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN’s
future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ
materially from those projected due to our short operating history,
limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in
APDN’s SEC reports and filings, including our Annual Report on Form 10-K
filed on December 6, 2016, and our subsequent quarterly reports on Form
10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which
are available at www.sec.gov.
APDN, undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170921005296/en/